Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [20]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V3316 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- Cytokeratin 8/18 Antibody
- Antibody type
- Monoclonal
- Description
- Bioreactor concentrate
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- 5D3
- Vial size
- 0.1 ml, 0.5 ml
- Storage
- Store the Cytokeratin 8/18 antibody at 2-8°C.
Submitted references In vitro model for DNA double-strand break repair analysis in breast cancer reveals cell type-specific associations with age and prognosis.
An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells.
Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
Parathyroid adenoma with prominent lymphocytic infiltrate.
Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Prevalence of molecular subtypes of invasive breast cancer: A retrospective study.
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer.
Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production.
Canine aural cholesteatoma: a histological and immunohistochemical study.
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.
A comparison of cell-cycle markers in skull base and sacral chordomas.
CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.
Multiple trichoblastomas in a dog.
Morphologic and immunohistochemical features of Merkel cells in the dog.
Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.
A preclinical xenograft model of prostate cancer using human tumors.
Deniz M, Kaufmann J, Stahl A, Gundelach T, Janni W, Hoffmann I, Keimling M, Hampp S, Ihle M, Wiesmüller L
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2016 Nov;30(11):3786-3799
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2016 Nov;30(11):3786-3799
An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
McCart Reed AE, Kutasovic JR, Vargas AC, Jayanthan J, Al-Murrani A, Reid LE, Chambers R, Da Silva L, Melville L, Evans E, Porter A, Papadimos D, Thompson EW, Lakhani SR, Simpson PT
The Journal of pathology 2016 Mar;238(4):489-94
The Journal of pathology 2016 Mar;238(4):489-94
Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells.
Venturelli L, Nappini S, Bulfoni M, Gianfranceschi G, Dal Zilio S, Coceano G, Del Ben F, Turetta M, Scoles G, Vaccari L, Cesselli D, Cojoc D
Scientific reports 2016 Feb 22;6:21629
Scientific reports 2016 Feb 22;6:21629
Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
Leo F, Bartels S, Mägel L, Framke T, Büsche G, Jonigk D, Christgen M, Lehmann U, Kreipe H
Virchows Archiv : an international journal of pathology 2016 Aug;469(2):191-201
Virchows Archiv : an international journal of pathology 2016 Aug;469(2):191-201
Parathyroid adenoma with prominent lymphocytic infiltrate.
Iliadis A, Koletsa T, Kostopoulos I, Karayannopoulou G
Case reports in pathology 2015;2015:705843
Case reports in pathology 2015;2015:705843
Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
Lawrence MG, Pook DW, Wang H, Porter LH, Frydenberg M, Kourambas J, Appu S, Poole C, Beardsley EK, Ryan A, Norden S, Papargiris MM, Risbridger GP, Taylor RA
The Prostate 2015 Sep;75(13):1475-83
The Prostate 2015 Sep;75(13):1475-83
Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M, Chibon F, Arnould L, Croce S, Ribeiro A, Perot G, Hostein I, Geha S, Bozon C, Garnier A, Lae M, Vincent-Salomon A, MacGrogan G
The American journal of surgical pathology 2015 Nov;39(11):1458-67
The American journal of surgical pathology 2015 Nov;39(11):1458-67
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A, Kalogeras KT, Wirtz RM, Alexopoulou Z, Bobos M, Zagouri F, Veltrup E, Timotheadou E, Gogas H, Pentheroudakis G, Pisanidis N, Magkou C, Christodoulou C, Bafaloukos D, Papakostas P, Aravantinos G, Pectasides D, Kalofonos HP, Fountzilas G
Journal of translational medicine 2015 May 29;13:171
Journal of translational medicine 2015 May 29;13:171
Prevalence of molecular subtypes of invasive breast cancer: A retrospective study.
Kumar N, Patni P, Agarwal A, Khan MA, Parashar N
Medical journal, Armed Forces India 2015 Jul;71(3):254-8
Medical journal, Armed Forces India 2015 Jul;71(3):254-8
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Linardou H, Kalogeras KT, Kronenwett R, Alexopoulou Z, Wirtz RM, Zagouri F, Scopa CD, Gogas H, Petraki K, Christodoulou C, Pavlakis K, Koutras AK, Samantas E, Patsea H, Pectasides D, Bafaloukos D, Fountzilas G
Anticancer research 2015 Jul;35(7):4023-36
Anticancer research 2015 Jul;35(7):4023-36
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer.
Caliari D, Zappulli V, Rasotto R, Cardazzo B, Frassineti F, Goldschmidt MH, Castagnaro M
BMC veterinary research 2014 Sep 25;10:185
BMC veterinary research 2014 Sep 25;10:185
Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production.
González-Mateo GT, Fernández-Míllara V, Bellón T, Liappas G, Ruiz-Ortega M, López-Cabrera M, Selgas R, Aroeira LS
PloS one 2014 Oct 3;9(10):e108477
PloS one 2014 Oct 3;9(10):e108477
Canine aural cholesteatoma: a histological and immunohistochemical study.
Banco B, Grieco V, Di Giancamillo M, Greci V, Travetti O, Martino P, Mortellaro CM, Giudice C
Veterinary journal (London, England : 1997) 2014 Jun;200(3):440-5
Veterinary journal (London, England : 1997) 2014 Jun;200(3):440-5
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.
Koletsa T, Stavridi F, Bobos M, Kostopoulos I, Kotoula V, Eleftheraki AG, Konstantopoulou I, Papadimitriou C, Batistatou A, Gogas H, Koutras A, Skarlos DV, Pentheroudakis G, Efstratiou I, Pectasides D, Fountzilas G
BMC clinical pathology 2014 Jun 23;14:28
BMC clinical pathology 2014 Jun 23;14:28
A comparison of cell-cycle markers in skull base and sacral chordomas.
Yakkioui Y, Temel Y, Creytens D, Jahanshahi A, Fleischeuer R, Santegoeds RG, Van Overbeeke JJ
World neurosurgery 2014 Jul-Aug;82(1-2):e311-8
World neurosurgery 2014 Jul-Aug;82(1-2):e311-8
CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.
Adamczyk A, Niemiec JA, Ambicka A, Mucha-Małecka A, Mituś J, Ryś J
Journal of molecular histology 2014 Feb;45(1):35-45
Journal of molecular histology 2014 Feb;45(1):35-45
Multiple trichoblastomas in a dog.
Campos AG, Cogliati B, Guerra JM, Matera JM
Veterinary dermatology 2014 Feb;25(1):48-e19
Veterinary dermatology 2014 Feb;25(1):48-e19
Morphologic and immunohistochemical features of Merkel cells in the dog.
Ramírez GA, Rodríguez F, Herráez P, Suárez-Bonnet A, Andrada M, Espinosa-de-Los-Monteros A
Research in veterinary science 2014 Dec;97(3):475-80
Research in veterinary science 2014 Dec;97(3):475-80
Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.
Verbeke S, Richard E, Monceau E, Schmidt X, Rousseau B, Velasco V, Bernard D, Bonnefoi H, MacGrogan G, Iggo RD
Breast cancer research : BCR 2014 Dec 20;16(6):504
Breast cancer research : BCR 2014 Dec 20;16(6):504
A preclinical xenograft model of prostate cancer using human tumors.
Lawrence MG, Taylor RA, Toivanen R, Pedersen J, Norden S, Pook DW, Frydenberg M, Australian Prostate Cancer BioResource., Papargiris MM, Niranjan B, Richards MG, Wang H, Collins AT, Maitland NJ, Risbridger GP
Nature protocols 2013 May;8(5):836-48
Nature protocols 2013 May;8(5):836-48
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC analysis of FFPE human colon carcinoma with Cytokeratin 8/18 antibody (clone 5D3). Required HIER: boil tissue sections in 10mM citrate buffer, pH 6, for 10-20 min.
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC analysis of FFPE human prostate carcinoma with Cytokeratin 8/18 antibody (clone 5D3). Required HIER: boil tissue sections in 10mM citrate buffer, pH 6, for 10-20 min.
